Wellvii has received U.S. Food and Drug Administration (FDA) clearance for its BP Go blood pressure monitoring technology, designed to provide non-invasive blood pressure measurements using a finger-based approach instead of a traditional arm cuff.

The compact device is intended to simplify blood pressure monitoring in home and remote-care settings. Its finger-based design aims to make measurements more convenient and portable while supporting connected health monitoring outside traditional clinical environments.

BP Go is part of Wellvii's focus on expanding remote patient monitoring and connected healthcare. By removing the need for a conventional arm cuff, the technology is designed to address some of the practical challenges associated with regular blood pressure monitoring.

The FDA clearance marks a regulatory milestone for Wellvii as it works to expand access to portable blood pressure monitoring technology for patients and healthcare providers.

The company plans to use the BP Go platform to support remote and home-based monitoring, helping bring blood pressure measurement closer to patients' everyday care environments.

 

Source: prnewswire.com

Report Abuse